Alger Mid Cap 40 ETF beats Russell Midcap Growth Index in Q3 2026 with key stock gains.

The Alger Mid Cap 40 ETF outperformed the Russell Midcap Growth Index in the third quarter of 2026, driven by strong contributions from stocks like Twist Bioscience Corp., Cloudflare Inc., and Repligen Corporation. However, some holdings such as FTAI Aviation Ltd., Astera Labs, Inc., and Modine Manufacturing Company detracted from performance. The ETF, launched in February 2021, had a net asset value of $23.65 and a closing price of $23.70 as of September 30, 2026, with a gross expense ratio of 0.77%. Alger, a $27.4 billion growth equity manager, continues to focus on actively managed growth equity investing, navigating market changes and innovation.

Following the Alger Mid Cap 40 ETF's Q3 2026 performance, key holdings show varied trading activity on Pluang as of Nov 13, 2026 01:21 WIB. Twist Bioscience Corp. (TWST) trades at USD 113.02 with a 1-day decline of 7.81%, while Cloudflare Inc. (NET) is priced at USD 317.52, up 0.77% in the last day. Repligen Corporation (RGEN) stands at USD 167.66, down 2.87% for the day, reflecting mixed investor sentiment in these growth stocks.